Keratin 10-positive orthokeratotic dysplasia: A new leucoplakia-type precancerous entity of the oral mucosa

Histopathology

Volumn 61, Issue 5, 2012, Pages 910-920

  Kobayashi, Takanori ^a,b   Maruyama, Satoshi ^a,b   Abé, Tatsuya ^a,b   Cheng, Jun ^b   Takagi, Ritsuo ^b   Saito, Chikara ^b   Saku, Takashi ^a,b  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Keratin 10; Oral mucosa; Orthokeratotic dysplasia; Potentially malignant oral mucosal lesion; Proliferative verrucous leucoplakia

Indexed keywords

CYTOKERATIN 10; CYTOKERATIN 13; CYTOKERATIN 17; CYTOKERATIN 19; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SCREENING; CARCINOMA IN SITU; FEMALE; GRANULAR CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; ORAL MUCOSAL DISEASE; ORTHOKERATOTIC DYSPLASIA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-10; KERATIN-13; KERATIN-17; KERATIN-19; KI-67 ANTIGEN; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84868117063     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04283.x     Document Type: Article

References (35)

1. Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I. Squamous epithelial dysplasia. In Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I eds. World Health Organization international histological classification of tumours, histological typing of cancer and precancer of the oral mucos. Berlin: Springer-Verlag, 1997; 24-26.
2. Gale N, Pilch BZ, Sidransky D et al. Epithelial precursor lesions. In Barnes L, Eveson JW, Reichart P et al. eds. World Health Organization classification of tumours, pathology and genetics, head and neck tumours. Lyon: IARC Press, 2005; 177-179.
3. Chi AC. Leukoplakia (leukokeratosis; erythroleukoplakia). In Neville BW, Damm DD, Allen CM et al. eds. Oral and maxillofacial pathology. St Louis: Saunders, 2005; 388-397.
4. Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2008; 44; 538-544.
5. McIntosh L, McCullough MJ, Farah CS. The assessment of diffused light illumination and acetic acid rinse (Microlux/Dl) in the visualisation of oral mucosal lesions. Oral Oncol. 2009; 45; e227-e231.
6. Kobayashi T, Maruyama S, Cheng J et al. Histopathological varieties of oral carcinoma in situ: diagnosis aided by immunohistochemistry dealing with the second basal cell layer as the proliferating center of oral mucosal epithelia. Pathol. Int. 2010; 60; 156-166.
7. Funayama A, Cheng J, Maruyama S et al. Enhanced expressions of podoplanin in oral carcinoma in-situ and squamous cell carcinoma. Pathobiology 2011; 78; 171-180.
8. Mikami T, Cheng J, Maruyama S et al. Emergence of keratin 17 versus. loss of keratin 13: their reciprocal immunohistochemical profiles in oral carcinoma in situ. Oral Oncol. 2011; 47; 497-503.
9. Syafriadi M, Cheng J, Jen KY, Ida-Yonemochi H, Suzuki M, Saku T. Two-phase appearance of oral epithelial dysplasia resulting from focal proliferation of parabasal cells and apoptosis of prickle cells. J. Oral Pathol. Med. 2005; 34; 140-149.
10. Takeda T, Sugihara K, Hirayama Y, Hirano M, Tanuma JI, Semba I. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J. Oral Pathol. Med. 2006; 35; 369-375.
11. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A. Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin. Cancer Res. 2008; 14; 2396-2404.
12. Alvarado CG, Maruyama S, Cheng J et al. Nuclear translocation of β-catenin synchronized with loss of E-cadherin in oral epithelial dysplasia with a characteristic two-phase appearance. Histopathology 2011; 59; 283-291.
13. Ahsan MS, Yamazaki M, Maruyama M et al. Differential expression of perlecan receptors, α-dystroglycan and ingegrin β1, before and after invasion of oral squamous cell carcinoma. J. Oral Pathol. Med. 2011; 40; 552-559.
14. Ikarashi T, Ida-Yonemochi H, Ohshiro K, Cheng J, Saku T. Intraepithelial expression of perlecan, a basement membrane-type heparan sulfate proteoglycan reflects dysplastic changes of the oral mucosal epithelium. J. Oral Pathol. Med. 2004; 33; 87-95.
15. Tilakaratne WM, Kobayashi T, Ida-Yonemochi H et al. Matrix metalloproteinase 7 and perlecan in oral epithelial dysplasia and carcinoma in situ: an aid for histopathologic recognition of their cell proliferation centers. J. Oral Pathol. Med. 2009; 38; 348-355.
16. Schaaij-Visser TB, Bremmer JF, Braakhuis BJ et al. Evaluation of cornulin, keratin 4, keratin expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Oral Oncol. 2010; 46; 123-127.
17. Aida J, Kobayashi T, Saku T et al. Short telomeres in an oral precancerous lesion: Q-FISH analysis of leukoplakia. J. Oral Pathol. Med. 2012; 41; 372-378.
18. Flaitz CM, Aguirre A, Tapia JL. Oral frictional hyperkeratosis. 2009. Available at: http://emedicine.medscape.com/ (accessed 27 June 2009).
19. Natarajan E, Woo SB. Benign alveolar ridge keratosis (oral lichen simplex chronicus): a distinct clinicopathologic entity. J. Am. Acad. Dermatol. 2008; 58; 151-157.
20. Woo SB, Lin D. Morsicatio mucosae oris-a chronic oral frictional keratosis, not a leukoplakia. J. Oral Maxillofac. Surg. 2009; 67; 140-146.
21. Chovanec M, Plzak J, Betka J, Brabec J, Kodet R, Smetana K Jr. Comparative analysis of alpha2, 3/2, 6-linked N-acetylneuraminic acid and cytokeratin expression in head and neck squamous cell carcinoma. Oncol. Rep. 2004; 12; 297-301.
22. Shear M, Pindborg JJ. Verrucous hyperplasia of the oral mucosa. Cancer 1980; 46; 1855-1862.
23. Slootweg PJ, Muller H. Verrucous hyperplasia or verrucous carcinoma. An analysis of 27 patients. J. Maxillofac. Surg. 1983; 11; 13-19.
24. Hansen LS, Olson JA, Silverman S Jr. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg. Oral Med. Oral Pathol. 1985; 60; 285-298.
25. El-Naggar AK, Reichart PA. Proliferative verrucous leukoplakia and precancerous conditions. In Barnes L, Eveson JW, Reichart P et al. eds. World Health Organization classification of tumours, pathology and genetics, head and neck tumours. Lyon: IARC Press, 2005; 180-181.
26. Bagan J, Scully C, Jimenez Y, Martorell M. Proliferative verrucous leukoplakia: a concise update. Oral Dis. 2010; 16; 328-332.
27. Van der Waal I, Reichart PA. Oral proliferative verrucous leukoplakia revisited. Oral Oncol. 2008; 44; 719-721.
28. Cabay RJ, Morton TH Jr, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J. Oral Pathol. Med. 2007; 36; 255-261.
29. Bagan JV, Murillo J, Poveda R, Gavalda C, Jimenez Y, Scully C. Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs. Oral Oncol. 2004; 40; 440-443.
30. Silverman S Jr, Gorsky M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1997; 84; 154-157.
31. Gouvea AF, Vargas PA, Coletta RD, Jorge J, Lopes MA. Clinicopathological features and immunohistochemical expression of p53, Ki-67, Mcm-2 and Mcm-5 in proliferative verrucous leukoplakia. J. Oral Pathol. Med. 2010; 39; 447-452.
32. Morton TH, Cabay RJ, Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: report of three cases. J. Oral Pathol. Med. 2007; 36; 315-318.
33. Kresty LA, Mallery SR, Knobloch TJ et al. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia. Cancer Epidemiol. Biomark. Prev. 2008; 17; 3179-3187.
34. Batsakis JG, Suarez P, El-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol. 1999; 35; 354-359.
35. Klanrit P, Sperandio M, Brown AL et al. DNA ploidy in proliferative verrucous leukoplakia. Oral Oncol. 2007; 43; 310-316.